![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » NEUROSCIENCE THERAPY CORP. NOW HAS EXCLUSIVE DISTRIBUTION RIGHTS IN NORTH AMERICA
NEUROSCIENCE THERAPY CORP. NOW HAS EXCLUSIVE DISTRIBUTION RIGHTS IN NORTH AMERICA
April 18, 2006
Neuroscience Therapy Corp. announced today that it has gained hold of the exclusive rights to the North American market to distribute its leading product P-Stim. It now holds rights in North, South and Central America and plans to thrive in these multi-billion dollar markets.
CNW Group (http://www.newswire.ca/en/releases/archive/April2006/18/c5027.html)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct